Literature DB >> 16048563

Influence of load of hepatitis A virus on disease severity and its relationship with clinical manifestations in patients with hepatitis A.

Shigehiko Sainokami1, Koichi Abe, Kazuyoshi Ishikawa, Kazuyuki Suzuki.   

Abstract

BACKGROUND AND AIM: The purpose of the present study was to investigate the influence of viral load on disease severity and analyze the possible relationship of the load of hepatitis A virus (HAV) with disease severity and laboratory findings.
METHODS: Fifty-eight patients diagnosed with acute hepatitis A were used in the current study, of whom 12 patients progressed to severe acute hepatitis (s-AH) defined on the basis of a prothrombin time (PT) of <40% and 46 patients were diagnosed as having mild acute hepatitis (m-AH). The load of HAV was measured with real-time polymerase chain reaction.
RESULTS: Peak viral load showed a significant correlation with alanine aminotransferase (ALT) (r = 0.363, P = 0.0048) and PT levels (r = -0.330, P = 0.0110). In terms of disease severity, there was a significant correlation with ALT (r = 0.462, P = 0.0012) and PT levels (r = 0.400, P = 0.0059) in the m-AH group, but not in the s-AH group. A significant positive correlation of peak viral load with the C-reactive protein level (r = 0.270, P = 0.0400) and a significant negative correlation of peak viral load with the platelet count (r = -0.313, P = 0.0015) was also found.
CONCLUSIONS: The load of HAV was closely correlated with liver damage and disease severity in m-AH, but not in s-AH. The load of HAV was also closely associated with the increase in C-reactive protein level and enhancement of thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16048563     DOI: 10.1111/j.1440-1746.2005.03908.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  High prevalence of antibodies against hepatitis A virus among captive nonhuman primates.

Authors:  Pattaratida Sa-nguanmoo; Nutchanart Thawornsuk; Pornpimol Rianthavorn; Angkana Sommanustweechai; Parntep Ratanakorn; Yong Poovorawan
Journal:  Primates       Date:  2009-10-10       Impact factor: 2.163

2.  Virological course of hepatitis A virus as determined by real time RT-PCR: Correlation with biochemical, immunological and genotypic profiles.

Authors:  Zahid Hussain; Bhudev C Das; Syed A Husain; Sunil K Polipalli; Tanzeel Ahmed; Nargis Begum; Subhash Medhi; Alice Verghese; Mohammad Raish; Apiradee Theamboonlers; Yong Poovorawan; Premashis Kar
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

3.  Hepatitis A virus genotype IA-infected patient with marked elevation of aspartate aminotransferase levels.

Authors:  Yoshifumi Miura; Tatsuo Kanda; Shin Yasui; Koji Takahashi; Yuki Haga; Reina Sasaki; Masato Nakamura; Shuang Wu; Shingo Nakamoto; Makoto Arai; Tsutomu Nishizawa; Hiroaki Okamoto; Osamu Yokosuka
Journal:  Clin J Gastroenterol       Date:  2016-11-15

4.  Clinical Factors and Viral Load Influencing Severity of Acute Hepatitis A.

Authors:  Hyun Woong Lee; Dong-Yeop Chang; Hong Ju Moon; Hye Young Chang; Eui-Cheol Shin; June Sung Lee; Kyung-Ah Kim; Hyung Joon Kim
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

Review 5.  Review: Viral infections and mechanisms of thrombosis and bleeding.

Authors:  M Goeijenbier; M van Wissen; C van de Weg; E Jong; V E A Gerdes; J C M Meijers; D P M Brandjes; E C M van Gorp
Journal:  J Med Virol       Date:  2012-10       Impact factor: 2.327

6.  Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus.

Authors:  Nan Nwe Win; Tatsuo Kanda; Masahiro Ogawa; Shingo Nakamoto; Yuki Haga; Reina Sasaki; Masato Nakamura; Shuang Wu; Naoki Matsumoto; Shunichi Matsuoka; Naoya Kato; Hiroshi Shirasawa; Osamu Yokosuka; Hiroaki Okamoto; Mitsuhiko Moriyama
Journal:  Int J Med Sci       Date:  2019-09-20       Impact factor: 3.738

Review 7.  Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Hiroshi Takahashi; Taku Mizutani; Naoki Matsumoto; Kazushige Nirei; Mitsuhiko Moriyama
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.